Intestinal microbiota influences clinical outcome and side effects of early breast cancer treatment/Experiment 12

From BugSigDB


Reviewed Marked as Reviewed by Svetlana up on 2024-7-23

Curated date: 2024/04/23

Curator: Scholastica

Revision editor(s): Scholastica

Subjects

Location of subjects
France
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Adverse effect adverse reaction,Adverse effect,adverse effect
Group 0 name Corresponds to the control (unexposed) group for case-control studies
No - increased BMI (Pre-Chemo)
Group 1 name Corresponds to the case (exposed) group for case-control studies
Yes - increased BMI (Pre-Chemo)
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Breast cancer patients before Chemotherapy with increased Body Mass Index (BMI)
Group 0 sample size Number of subjects in the control (unexposed) group
30
Group 1 sample size Number of subjects in the case (exposed) group
34
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
None

Lab analysis

Sequencing type
WMS
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
Not specified
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Ion Torrent

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
PLS-DA (Partial least square discriminant analysis)
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
Yes


Signature 1

Reviewed Marked as Reviewed by Svetlana up on 2024-7-23

Curated date: 2024/04/23

Curator: Scholastica

Revision editor(s): Scholastica

Source: Supplementary Fig. S6B

Description: Differentially significant abundant taxa in breast cancer patients before Chemotherapy with increased BMI compared to those without increased BMI

Abundance in Group 1: increased abundance in Yes - increased BMI (Pre-Chemo)

NCBI Quality ControlLinks
Bacteroides stercoris
Parabacteroides merdae
Anaeromassilibacillus sp. An250
Bacteroides finegoldii
Bacteroides cellulosilyticus
Ruthenibacterium lactatiformans
Bifidobacterium catenulatum
Coprobacillus cateniformis
Coprobacter secundus
Prevotella disiens
Phocaeicola vulgatus
Firmicutes bacterium CAG:94
Segatella copri
Butyricimonas virosa
Blautia obeum
Bifidobacterium animalis
Ruminococcus sp. CAG:403
Adlercreutzia equolifaciens
Bacteroides eggerthii
Clostridium paraputrificum
Eubacterium sp. CAG:180
Firmicutes bacterium CAG:95
Dialister succinatiphilus
Anaerotruncus sp. CAG:528
Parabacteroides distasonis
Clostridiales bacterium 1_7_47FAA
Candidatus Gastranaerophilales bacterium
Oscillibacter sp. 57_20
Adlercreutzia equolifaciens subsp. celatus
Clostridium disporicum
Thomasclavelia ramosa
Oscillibacter sp. CAG:241
Mitsuokella jalaludinii
Dielma fastidiosa
Veillonella atypica
Flavonifractor sp. An100
Turicimonas muris
Odoribacter splanchnicus
Bifidobacterium bifidum
Prevotella sp. CAG:1185

Revision editor(s): Scholastica

Signature 2

Reviewed Marked as Reviewed by Svetlana up on 2024-7-23

Curated date: 2024/04/23

Curator: Scholastica

Revision editor(s): Scholastica

Source: Supplementary Fig. S6B

Description: Differentially significant abundant taxa in breast cancer patients before Chemotherapy with increased BMI compared to those without increased BMI

Abundance in Group 1: decreased abundance in Yes - increased BMI (Pre-Chemo)

NCBI Quality ControlLinks
Alistipes finegoldii
Alistipes onderdonkii
Bacteroides clarus
Bacteroides intestinalis
Bacteroides nordii
Bacteroides ovatus
Bacteroides sp. CAG:443
Cloacibacillus porcorum
Collinsella aerofaciens
Collinsella intestinalis
Coprococcus eutactus
Desulfovibrio piger
Dorea sp. CAG:317
Escherichia coli
Phascolarctobacterium faecium
Phascolarctobacterium succinatutens
Phocaeicola dorei
Phocaeicola plebeius
Pseudoflavonifractor sp. An184
Roseburia sp. CAG:182
Streptococcus oralis
Streptococcus parasanguinis
Sutterella parvirubra
Streptococcus infantis
Eubacterium ramulus
Blautia hydrogenotrophica
Ruminococcus callidus
Butyricicoccus pullicaecorum
Roseburia sp. CAG:303
Veillonella parvula
Firmicutes bacterium CAG:145
Oscillibacter sp. PC13
Enorma massiliensis
Veillonella dispar
Streptococcus salivarius
Eshraghiella crossota
Desulfovibrionaceae bacterium
Parabacteroides johnsonii
Ruminococcaceae bacterium D5
Veillonella sp. T11011-6
Bacteroides uniformis
Veillonella infantium
Enterocloster clostridioformis
Streptococcus mitis
[Lactobacillus] rogosae
Bacteroides fragilis
Eisenbergiella tayi
[Ruminococcus] lactaris
Lachnospira pectinoschiza
Gemella sanguinis
Ruminococcus bromii
Eubacterium sp. CAG:251

Revision editor(s): Scholastica